High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma

Table 9

Univariate analysis of prognostic risk factors for malignant mesothelioma.

Clinical features	(%)	95% CI (SMO)	(SMO)	95% CI (GLI1)	(GLI1)
Sex
Male	60	2.723 (1.149-6.454)	0.023	3.080 (1.311-7.235)	0.01
Female	70
Age (years)
<60	39	0.653 (0.274-1.554)	0.335	0.650 (0.272-1.552)	0.332
≥60	91
Asbestos exposure history
Yes	85	0.331 (0.128-0.857)	0.023	0.269 (0.099-0.732)	0.010
No	45
Pathological changes
Pleural	60	0.521 (0.204-1.328)	0.172	0.730 (0.325-1.643)	0.447
Peritoneal	70
P53
Negative	51	0.506 (0.222-1.151)	0.104	0.619 (0.277-1.386)	0.244
Positive	79